Use of antibodies against a tumorassociated antigen
Details for Australian Patent Application No. 2003250570 (hide)
International Classifications
Event Publications
16 October 2003 Complete Application Filed
Priority application(s): A 1217/2002 12.08.02 AT
8 April 2004 Application Open to Public Inspection
Published as AU-B-2003250570
22 October 2009 Application Accepted
Published as AU-B-2003250570
18 February 2010 Standard Patent Sealed
16 September 2010 Assignment Registered
Igeneon Krebs-Immuntherapie Forschungs-und Entwicklungs-AG The patent has been assigned to Meridian Biopharmaceuticals GmbH; Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; greenovation Biotech GmbH
15 September 2011 Assignment Registered
Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; Greenovation Biotech GmbH; Meridian Biopharmaceuticals GmbH The patent has been assigned to Greenovation Biotech GmbH; Meridian Biopharmaceuticals GmbH
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003250571-MODULE-LIKE CONSTRUCTED INTERNAL COMBUSTION ENGINE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser